Thall PF - Search Results

1

Caspase 2 and caspase 3 as predictors of complete remission and survival in adults with acute lymphoblastic leukemia.

Faderl S, Thall PF, Kantarjian HM, Talpaz M, Harris D, Van Q, Beran M, Kornblau SM, Pierce S, Estrov Z. Faderl S, et al. Among authors: thall pf. Clin Cancer Res. 1999 Dec;5(12):4041-7. Clin Cancer Res. 1999. PMID: 10632337

2

Treatment of newly diagnosed acute myelogenous leukemia with granulocyte-macrophage colony-stimulating factor (GM-CSF) before and during continuous-infusion high-dose ara-C + daunorubicin: comparison to patients treated without GM-CSF.

Estey E, Thall PF, Kantarjian H, O'Brien S, Koller CA, Beran M, Gutterman J, Deisseroth A, Keating M. Estey E, et al. Among authors: thall pf. Blood. 1992 May 1;79(9):2246-55. Blood. 1992. PMID: 1571541 Free article.

3

Use of granulocyte colony-stimulating factor before, during, and after fludarabine plus cytarabine induction therapy of newly diagnosed acute myelogenous leukemia or myelodysplastic syndromes: comparison with fludarabine plus cytarabine without granulocyte colony-stimulating factor.

Estey E, Thall P, Andreeff M, Beran M, Kantarjian H, O'Brien S, Escudier S, Robertson LE, Koller C, Kornblau S, et al. Estey E, et al. J Clin Oncol. 1994 Apr;12(4):671-8. doi: 10.1200/JCO.1994.12.4.671. J Clin Oncol. 1994. PMID: 7512125 Clinical Trial.

4

Analysis of CD7 expression in acute myelogenous leukemia: martingale residual plots combined with 'optimal' cutpoint analysis reveals absence of prognostic significance.

Kornblau SM, Thall P, Huh YO, Estey E, Andreeff M. Kornblau SM, et al. Leukemia. 1995 Oct;9(10):1735-41. Leukemia. 1995. PMID: 7564518

5

New statistical strategy for monitoring safety and efficacy in single-arm clinical trials.

Thall PF, Simon RM, Estey EH. Thall PF, et al. J Clin Oncol. 1996 Jan;14(1):296-303. doi: 10.1200/JCO.1996.14.1.296. J Clin Oncol. 1996. PMID: 8558211

6

Treatment of newly diagnosed acute promyelocytic leukemia without cytarabine.

Estey E, Thall PF, Pierce S, Kantarjian H, Keating M. Estey E, et al. Among authors: thall pf. J Clin Oncol. 1997 Feb;15(2):483-90. doi: 10.1200/JCO.1997.15.2.483. J Clin Oncol. 1997. PMID: 9053469 Clinical Trial.

7

Design and analysis of trials of salvage therapy in acute myelogenous leukemia.

Estey E, Thall P, David C. Estey E, et al. Cancer Chemother Pharmacol. 1997;40 Suppl:S9-12. doi: 10.1007/s002800051054. Cancer Chemother Pharmacol. 1997. PMID: 9272127 Review.

8

Association between increased body mass index and a diagnosis of acute promyelocytic leukemia in patients with acute myeloid leukemia.

Estey E, Thall P, Kantarjian H, Pierce S, Kornblau S, Keating M. Estey E, et al. Leukemia. 1997 Oct;11(10):1661-4. doi: 10.1038/sj.leu.2400783. Leukemia. 1997. PMID: 9324286

9

Effect of diagnosis (refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, or acute myeloid leukemia [AML]) on outcome of AML-type chemotherapy.

Estey E, Thall P, Beran M, Kantarjian H, Pierce S, Keating M. Estey E, et al. Blood. 1997 Oct 15;90(8):2969-77. Blood. 1997. PMID: 9376577 Free article.

10

Philadelphia chromosome-positive myeloid cells in the peripheral blood of chronic myelogenous leukemia patients: comparison with the frequency detected in cycling cells of the bone marrow.

Seong D, Thall P, Kantarjian HM, Talpaz M, Swantkowski J, Xu J, Shen Y, Glassman A, Ramagli L, Siciliano MJ. Seong D, et al. Clin Cancer Res. 1998 Apr;4(4):861-7. Clin Cancer Res. 1998. PMID: 9563879

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

273 results

Search Page

Filters